fda warning letter bpc-157 compounding pharmacy An FDA Committee Just Voted

An FDA Committee Just Voted in Favor of PeptidesDespite the Agency's Opposition FDA is moving to restrict mass marketed compounded GLP 1 products that aren't FDA approved, warning companies they can't market them as equivalent to approved drugs and signaling stronger enforcement to protect patients from unverified An FDA advisory committee voted Thursday to remove compounding restrictions on four peptides despite little evidence the products are safe or effective for medical use. In a series of 8 6 votes (with The Food and Drug Administration's committee on compounded drugs broke with agency scientists and voted in favor of adding peptides to the list of substances compounding pharmacies can make. Follow the link

SKU: 92371884927 · From cantondelareina.com.ar